Streetbeat News

Stock Prices

EVAX

Trading for EVAX was halted and then resumed at 8:55 AM ET, with updated quotation resumption times following the release of news.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:55 pm

NXTP

NextPlay Technologies Inc has filed an appeal against a delisting notice from Nasdaq. A hearing is scheduled for February 27, 2024, to determine the future listing status of the company, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:54 pm

ADM

Archer-Daniels-Midland (ADM) shares have dropped as the company's CFO has been placed on leave pending an investigation into the accounting practices of its nutrition segment.

Portfolio Pulse from Luke J Jacobi

January 22, 2024 | 1:53 pm

CELH

PEP

Celsius Holdings Inc (CELH) shares are recovering after a 12.7% drop on Friday due to a downgrade by BofA Securities. The rebound is attributed to the company's expansion into Canada, the U.K., and Ireland. PepsiCo Inc (PEP) will be the exclusive distributor in Canada, with sales starting this month, while Suntory Beverage & Food will handle sales and distribution in the U.K. and Ireland, expected to begin this year.

Portfolio Pulse from Adam Eckert

January 22, 2024 | 1:50 pm

AZN

AstraZeneca's stock is trading higher following the announcement that its asthma treatment, Airsupra, has been approved by the FDA as an anti-inflammatory rescue medication.

Portfolio Pulse from Luke J Jacobi

January 22, 2024 | 1:50 pm

BABA

Alibaba shares are trading lower due to weakness in Chinese markets after China decided to keep its prime interest rates unchanged, contrary to investor expectations for economic relief.

Portfolio Pulse from Luke J Jacobi

January 22, 2024 | 1:49 pm

PDD

PDD shares are trading lower due to weakness in Chinese markets after China decided to keep its prime interest rates unchanged, contrary to investor expectations for economic relief.

Portfolio Pulse from Luke J Jacobi

January 22, 2024 | 1:49 pm

NTES

NetEase shares are trading lower due to weakness in Chinese markets after China's decision to leave its prime rates unchanged.

Portfolio Pulse from Luke J Jacobi

January 22, 2024 | 1:46 pm

AISP

BYTS

Airship AI Holdings, Inc. (AISP) issued a stockholder letter reflecting on 2023 achievements, including a Nasdaq listing through a merger with BYTE Acquisition Corp. (BYTS). The company anticipates triple-digit revenue growth and positive EBITDA in 2024, backed by a $11.8M backlog and a $140M pipeline. Demand from Fortune 500 and government agencies, especially for border protection technologies, is driving growth. Investments in internal capabilities and new product launches, such as the Outpost AI edge appliance, are expected to capitalize on the $7.0 billion edge AI market.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:46 pm

BDRX

SNY

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) CEO Stephen Stamp released a shareholder letter detailing the company's progress in 2023 and outlining expected milestones for 2024. Biodexa, which focuses on treatments for diseases with unmet medical needs, including Type 1 diabetes and rare brain cancers, has transitioned from a single-asset company to a multi-asset therapeutics company. Key developments include the in-licensing of tolimidone for Type 1 diabetes, advancement of MTX110 for Glioblastoma Multiforme, and progress on MTD217 for leptomeningeal disease. The company expects to announce various preclinical and clinical data in 2024 and has raised $6.0 million to support these efforts.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:45 pm